glp-1 fast food How the fast-food industry is responding in the booming era of GLP-1s GLP-1 Food Industry Impact: Cornell

Ryan said that we do need better evidence around whether some individuals can maintain weight loss after coming off GLP-1s, but she thinks what Calibrate is doing is sharing the decision-making with the patient and trying to adapt to the environment where drugs may not always be available. Since Calibrate has come onto the market, results were published from a much larger, peer-reviewed study funded by the Ozempic manufacturer Novo Nordisk in 2022

GLP-1RAs may provide therapeutic opportunities in conditions such as PCOS and obesity-related infertility

Beware of appetite suppressant products sold online

Department of Health and Human Services Food and Drug Administration (FDA)